Mersana Therapeutics Inc (MRSN) Stock Analysis

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NASDAQ

Key Metrics

• Price: $29.08

About Mersana Therapeutics Inc

Mersana Therapeutics, Inc. is a clinical-stage biopharmaceutical company headquartered in Cambridge, Massachusetts, dedicated to pioneering innovative Antibody Drug Conjugates (ADCs) to meet significant unmet needs in oncology. The company is advancing a strong pipeline of proprietary ADCs designed to enhance targeted therapy efficacy and improve patient outcomes. With a commitment to transforming cancer treatment, Mersana continues to progress through pivotal clinical trials and collaborates...

GNG Research provides proprietary Safety Scores, Quality Scores, Fair Value estimates, and Valuation Ratings for Mersana Therapeutics Inc and 4,500+ other companies. Learn more about GNG Pro.

Frequently Asked Questions

Does MRSN pay dividends?

Mersana Therapeutics Inc (MRSN) does not currently pay a regular dividend.